Search results for: 'plot development india'

This research service focuses on the US Department of Defense (DoD) 2025 spending requests for the research, development, test, and evaluation; procurement; and operations and maintenance categories. The analyst has segmented the budget request by the military department and 20 technology areas, including aircraft; ships; ground vehicles; and comma...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

02 Jun 2021  |  North America  |  Market Research

Global Benchmarking of Select Cities and their Data and Digital Strategies, 2021

Cities with a Well-structured Digital Strategy will be able to Dramatically Enhance Livability

Infographics

×

Digitization is the bedrock of new technology and services expansion, new mobility solutions, and smart applications in city management. Its purview extends across a city’s digital performance and digital strategy. In terms of digital performance, this measures how a city fares in terms of smartphone penetration, 4G coverage and speed, its 5G outlo...

South America has experienced significant growth in the last 10 years, but it was focused only on specific countries. Driven by the Brazilian market, the continent has experience an influx of new destinations, especially from the North American market. The low average income GDP per capita is a significant deterrent, and the complicated political ...

Although the Internet of Things (IoT) has been a buzzword for a long time, its penetration in the analytical instrumentation market has been limited when compared to other industrial markets. With key end users in the pharmaceuticals, food and beverage, and government sectors, the market proceeds with great caution (in terms of technology) as it de...

17 Oct 2022  |  North America  |  Market Research

State of the Global Video Conferencing Devices Market—Forecast to 2027

Post-pandemic Market Normalization and Economic Headwinds Put Brakes on Growth in 2022: Long-term Momentum for Video-First Enterprise will Continue

Infographics

×

The $3.85 billion global video conferencing devices market is undergoing seismic changes in the wake of massive work, workplace, and workforce transformation. Driven by the shift to remote work, video adoption saw hyper-growth during the pandemic years. The market is currently undergoing significant normalization, as it gets aligned with the new fu...

09 Jan 2020  |  North America  |  Market Research

Analysis of the Global Cardiac Monitoring Market, Forecast to 2023

New Age Technology Poised to Change the Way Care is Delivered

Infographics

×

Key Issues Addressed

The cardiac monitoring market is at a juncture where classical point-of-care monitoring devices are being commoditized, while advances in the understanding of patient needs have resulted in upgraded versions of cardiac monitors entering the market. The classical point-of-care electrocardiogram, as a technology, is at a stage where innovation is foc...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...